Who invested in Elevation Oncology

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2023, from 1 source

Latest round: Round, $50MJun 2023
Investors: 5

See who backed them

The rounds

Jun 2023
Round$50M
Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

Shawn LelandExecutive Officer, Director, Promoteri
Steven ElmsExecutive Officer, Director, Promoteri

On the board, as filediAndrew PhillipsColin WalshLori HuRichard GasterTimothy Clackson

Everyone who backed them

Qiming Venture PartnersVC firm1round

Janus Henderson InvestorsPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

Vivo CapitalPrivate equity1round

Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Elevation Oncology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site

Quick answers about Elevation Oncology

Who invested in Elevation Oncology?

Elevation Oncology's investors include Qiming Venture Partners, Janus Henderson Investors, Cormorant Asset Management, Vivo Capital and Samsara BioCapital.

How much has Elevation Oncology raised?

Elevation Oncology has raised $50M across 1 round since 2023.

When did Elevation Oncology last raise?

Elevation Oncology's most recent round was an Undisclosed round of $50M in Jun 2023.

What was Elevation Oncology's biggest round?

Its most recent round, $50M in Jun 2023, is also its largest on record.

Who backed Elevation Oncology first?

Elevation Oncology's first round on record, in Jun 2023, was backed by Qiming Venture Partners, Janus Henderson Investors and Cormorant Asset Management and 2 others.